US Stock MarketDetailed Quotes

LRMR Larimar Therapeutics

Watchlist

7.680
+0.240+3.23%

Close Aug 9 16:00 ET

7.680
0.0000.00%

Post 20:01 ET

490.03MMarket Cap-6857P/E (TTM)

Larimar Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual

YOY

Hide blank lines

(Q2)Jun 30, 2024

(Q1)Mar 31, 2024

(FY)Dec 31, 2023

(Q4)Dec 31, 2023

(Q3)Sep 30, 2023

(Q2)Jun 30, 2023

(Q1)Mar 31, 2023

(FY)Dec 31, 2022

(Q4)Dec 31, 2022

(Q3)Sep 30, 2022

Operating Cash Flow (Indirect Method)

Cash flow from continuing operating activities

-89.93%-13.99M

-37.88%-10.41M

-21.36%-33.46M

-40.03%-9.34M

-56.52%-9.2M

1.62%-7.37M

-0.24%-7.55M

34.52%-27.57M

15.74%-6.67M

51.82%-5.88M

Net income from continuing operations

-158.51%-21.63M

-124.55%-14.65M

-4.51%-36.95M

-37.86%-12.99M

-8.94%-9.06M

3.47%-8.37M

27.03%-6.53M

30.18%-35.36M

-3.19%-9.43M

50.49%-8.32M

Depreciation and amortization

14.47%87K

2.56%80K

-2.20%311K

3.85%81K

-1.30%76K

-6.17%76K

-4.88%78K

-2.45%318K

-11.36%78K

-12.50%77K

Other non cash items

-59.26%-43K

-79.17%-43K

-78.26%-82K

-33.33%-24K

46.15%-7K

-170.00%-27K

-380.00%-24K

-406.67%-46K

---18K

---13K

Change In working capital

765.91%7.07M

215.90%2.66M

-250.45%-2.51M

31.29%2.31M

-288.52%-1.46M

-88.97%-1.06M

-660.26%-2.3M

-38.91%1.67M

581.64%1.76M

-74.69%775K

-Change in prepaid assets

-316.86%-1.41M

-173.32%-272K

-422.06%-1.07M

-515.38%-486K

-0.66%-612K

-168.28%-338K

278.37%371K

-106.36%-204K

-89.57%117K

-443.50%-608K

-Change in payables and accrued expense

1,285.25%8.44M

210.44%2.95M

-177.36%-1.43M

72.31%2.82M

-162.38%-859K

33.83%-712K

-2,713.68%-2.67M

918.67%1.84M

211.22%1.64M

-52.19%1.38M

-Change in other current assets

450.00%42K

-416.67%-19K

-167.74%-21K

-600.00%-25K

66.67%10K

-163.16%-12K

500.00%6K

112.40%31K

101.27%5K

-95.52%6K

Cash from discontinued investing activities

Operating cash flow

-89.93%-13.99M

-37.88%-10.41M

-21.36%-33.46M

-40.03%-9.34M

-56.52%-9.2M

1.62%-7.37M

-0.24%-7.55M

34.52%-27.57M

15.74%-6.67M

51.82%-5.88M

Investing cash flow

Cash flow from continuing investing activities

-545.38%-63.49M

-174.11%-68.36M

136.67%33.35M

94.97%-2.63M

-1,272.04%-46.43M

72.16%-9.84M

92.25M

-476.35%-90.96M

-904.84%-52.23M

50.17%-3.38M

Net PPE purchase and sale

----

-64.00%-164K

---164K

--0

----

69.97%-100K

--0

Net investment purchase and sale

-542.59%-63.22M

-174.11%-68.36M

136.89%33.52M

95.28%-2.47M

-1,272.04%-46.43M

72.08%-9.84M

--92.25M

-470.83%-90.86M

-903.72%-52.23M

47.92%-3.38M

Cash from discontinued investing activities

Investing cash flow

-545.38%-63.49M

-174.11%-68.36M

136.67%33.35M

94.97%-2.63M

-1,272.04%-46.43M

72.16%-9.84M

--92.25M

-476.35%-90.96M

-904.84%-52.23M

50.17%-3.38M

Financing cash flow

Cash flow from continuing financing activities

-334K

162.15M

-99.96%30K

30K

278.46%75.26M

-316K

Net common stock issuance

---345K

--162.15M

--0

278.46%75.26M

---316K

----

Proceeds from stock option exercised by employees

----

--30K

--0

--30K

----

--0

----

Cash from discontinued financing activities

Financing cash flow

---334K

--162.15M

-99.96%30K

--0

-99.96%30K

--0

278.46%75.26M

---316K

280.05%75.57M

Net cash flow

Beginning cash position

-1.24%111.46M

-0.27%28.09M

-60.57%28.16M

-54.16%40.06M

353.90%95.66M

76.62%112.86M

-60.57%28.16M

2.80%71.44M

19.93%87.39M

-70.72%21.08M

Current changes in cash

-352.33%-77.81M

-1.56%83.38M

99.82%-76K

79.78%-11.97M

-183.85%-55.6M

59.83%-17.2M

1,224.37%84.7M

-2,320.22%-43.27M

-4,047.20%-59.22M

7,309.05%66.31M

End cash Position

-64.82%33.65M

-1.24%111.46M

-0.27%28.09M

-54.16%40.06M

353.90%95.66M

76.62%112.86M

-60.57%28.16M

19.93%87.39M

Free cash flow

-93.65%-14.26M

-37.88%-10.41M

-21.52%-33.62M

-42.49%-9.51M

-56.52%-9.2M

2.91%-7.37M

-0.24%-7.55M

34.80%-27.67M

15.83%-6.67M

52.95%-5.88M

Currency Unit

USD

Accounting Standards

US-GAAP

Audit Opinions

Unqualified Opinion

	(Q2)Jun 30, 2024	(Q1)Mar 31, 2024	(FY)Dec 31, 2023	(Q4)Dec 31, 2023	(Q3)Sep 30, 2023	(Q2)Jun 30, 2023	(Q1)Mar 31, 2023	(FY)Dec 31, 2022	(Q4)Dec 31, 2022	(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities	-89.93%-13.99M	-37.88%-10.41M	-21.36%-33.46M	-40.03%-9.34M	-56.52%-9.2M	1.62%-7.37M	-0.24%-7.55M	34.52%-27.57M	15.74%-6.67M	51.82%-5.88M
Net income from continuing operations	-158.51%-21.63M	-124.55%-14.65M	-4.51%-36.95M	-37.86%-12.99M	-8.94%-9.06M	3.47%-8.37M	27.03%-6.53M	30.18%-35.36M	-3.19%-9.43M	50.49%-8.32M
Depreciation and amortization	14.47%87K	2.56%80K	-2.20%311K	3.85%81K	-1.30%76K	-6.17%76K	-4.88%78K	-2.45%318K	-11.36%78K	-12.50%77K
Other non cash items	-59.26%-43K	-79.17%-43K	-78.26%-82K	-33.33%-24K	46.15%-7K	-170.00%-27K	-380.00%-24K	-406.67%-46K	---18K	---13K
Change In working capital	765.91%7.07M	215.90%2.66M	-250.45%-2.51M	31.29%2.31M	-288.52%-1.46M	-88.97%-1.06M	-660.26%-2.3M	-38.91%1.67M	581.64%1.76M	-74.69%775K
-Change in prepaid assets	-316.86%-1.41M	-173.32%-272K	-422.06%-1.07M	-515.38%-486K	-0.66%-612K	-168.28%-338K	278.37%371K	-106.36%-204K	-89.57%117K	-443.50%-608K
-Change in payables and accrued expense	1,285.25%8.44M	210.44%2.95M	-177.36%-1.43M	72.31%2.82M	-162.38%-859K	33.83%-712K	-2,713.68%-2.67M	918.67%1.84M	211.22%1.64M	-52.19%1.38M
-Change in other current assets	450.00%42K	-416.67%-19K	-167.74%-21K	-600.00%-25K	66.67%10K	-163.16%-12K	500.00%6K	112.40%31K	101.27%5K	-95.52%6K
Cash from discontinued investing activities
Operating cash flow	-89.93%-13.99M	-37.88%-10.41M	-21.36%-33.46M	-40.03%-9.34M	-56.52%-9.2M	1.62%-7.37M	-0.24%-7.55M	34.52%-27.57M	15.74%-6.67M	51.82%-5.88M
Investing cash flow
Cash flow from continuing investing activities	-545.38%-63.49M	-174.11%-68.36M	136.67%33.35M	94.97%-2.63M	-1,272.04%-46.43M	72.16%-9.84M	92.25M	-476.35%-90.96M	-904.84%-52.23M	50.17%-3.38M
Net PPE purchase and sale	----	----	-64.00%-164K	---164K	--0	----	----	69.97%-100K	--0	--0
Net investment purchase and sale	-542.59%-63.22M	-174.11%-68.36M	136.89%33.52M	95.28%-2.47M	-1,272.04%-46.43M	72.08%-9.84M	--92.25M	-470.83%-90.86M	-903.72%-52.23M	47.92%-3.38M
Cash from discontinued investing activities
Investing cash flow	-545.38%-63.49M	-174.11%-68.36M	136.67%33.35M	94.97%-2.63M	-1,272.04%-46.43M	72.16%-9.84M	--92.25M	-476.35%-90.96M	-904.84%-52.23M	50.17%-3.38M
Financing cash flow
Cash flow from continuing financing activities	-334K	162.15M	-99.96%30K	0	30K	0	0	278.46%75.26M	-316K
Net common stock issuance	---345K	--162.15M	--0	--0	--0	--0	--0	278.46%75.26M	---316K	----
Proceeds from stock option exercised by employees	----	----	--30K	--0	--30K	----	----	--0	--0	----
Cash from discontinued financing activities
Financing cash flow	---334K	--162.15M	-99.96%30K	--0	-99.96%30K	--0	--0	278.46%75.26M	---316K	280.05%75.57M
Net cash flow
Beginning cash position	-1.24%111.46M	-0.27%28.09M	-60.57%28.16M	-54.16%40.06M	353.90%95.66M	76.62%112.86M	-60.57%28.16M	2.80%71.44M	19.93%87.39M	-70.72%21.08M
Current changes in cash	-352.33%-77.81M	-1.56%83.38M	99.82%-76K	79.78%-11.97M	-183.85%-55.6M	59.83%-17.2M	1,224.37%84.7M	-2,320.22%-43.27M	-4,047.20%-59.22M	7,309.05%66.31M
End cash Position	-64.82%33.65M	-1.24%111.46M	-0.27%28.09M	-0.27%28.09M	-54.16%40.06M	353.90%95.66M	76.62%112.86M	-60.57%28.16M	-60.57%28.16M	19.93%87.39M
Free cash flow	-93.65%-14.26M	-37.88%-10.41M	-21.52%-33.62M	-42.49%-9.51M	-56.52%-9.2M	2.91%-7.37M	-0.24%-7.55M	34.80%-27.67M	15.83%-6.67M	52.95%-5.88M
Currency Unit	USD	USD	USD	USD	USD	USD	USD	USD	USD	USD
Accounting Standards	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP	US-GAAP
Audit Opinions	--	--	Unqualified Opinion	--	--	--	--	Unqualified Opinion	--	--

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List

Overall